These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1825940)

  • 1. Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.
    Tooze JA; Bevan DH
    Clin Exp Immunol; 1991 Mar; 83(3):423-9. PubMed ID: 1825940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL).
    Marquart HV; Grønbaek K; Christensen BE; Svehag SE; Leslie RG
    Clin Exp Immunol; 1995 Dec; 102(3):575-81. PubMed ID: 8536375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia.
    Lowe J; Brown B; Hardie D; Richardson P; Ling N
    Immunol Lett; 1989 Jan; 20(2):103-9. PubMed ID: 2523865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype analysis of B-CLL lymphoma and immunocytoma.
    Martinsson U; Sundström C; Glimelius B
    APMIS; 1989 Nov; 97(11):1025-32. PubMed ID: 2531599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic heterogeneity of B cell chronic lymphocytic leukaemia.
    Merson A; Brochier J
    Immunol Lett; 1988 Dec; 19(4):269-71. PubMed ID: 3266609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
    Matsumoto AK; Kopicky-Burd J; Carter RH; Tuveson DA; Tedder TF; Fearon DT
    J Exp Med; 1991 Jan; 173(1):55-64. PubMed ID: 1702139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.
    Fischer E; Delibrias C; Kazatchkine MD
    J Immunol; 1991 Feb; 146(3):865-9. PubMed ID: 1703182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
    Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CR2 receptor (CD21) shows increased expression in the more differentiated cells of an antigen-specific B cell line.
    Pillemer SR; Tsokos GC; Barbieri SA; Balow JE; Golding B
    Cell Immunol; 1990 Feb; 125(2):386-95. PubMed ID: 1688740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics.
    Korver W; Singh S; Liu S; Zhao X; Yonkovich S; Sweeney A; Anton K; Lomas WE; Greenwood R; Smith A; Tran DH; Shinkawa P; Jimenez M; Yeung P; Aguilar G; Palencia S; Vatta P; Mueller M; Zhan X; Newton EM; Liu Y; Zhao J; Emtage P; Levy MD; Hsi ED; Funk WD; Abo A
    Br J Haematol; 2007 May; 137(4):307-18. PubMed ID: 17456053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
    Roliński J; Rupniewska ZM; Wasik-Szczepanek E
    Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes.
    Marti GE; Zenger V; Caproaso NE; Brown M; Washington GC; Carter P; Schechter G; Noguchi P
    Anal Quant Cytol Histol; 1989 Oct; 11(5):315-23. PubMed ID: 2803444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
    Rayhel EJ; Dehoff MH; Holers VM
    J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.